IDXX
IDEXX Laboratories, Inc.
Diagnostics & Research · Healthcare · United States
575.98
close · 2026-10-29
value
16
cheaper than peers16
quality
84
stronger fundamentals84
ranked against
Diagnostics & Research
value
quality
31 peers
Value inputs
| measure | company | vs peers |
| forward P/E | 34.40× | 38 |
| EV to EBITDA | 29.22× | 32 |
| price to sales | 10.15× | 24 |
| price to book | 28.17× | 12 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | 35.0% | 95 |
| return on equity | 74.2% | 95 |
| revenue growth | 9.7% | 44 |
| debt to equity | 68.0% | 40 |
4 of 4 measures available
Facts
| market cap | $45B |
| free cash flow | $909.4M |
| employees | 11,000 |
| first trade | 1991-06-21 |
| next earnings | 2026-11-02 |
| fundamentals updated | 2026-08-07 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | 13.08 | 10.67 | 10.06 | 8.03 |
| free cash flow | $1.04B | $798.1M | $772.9M | $384.1M |
| net income | $1.06B | $887.9M | $845.0M | $679.1M |
| revenue | $4.30B | $3.90B | $3.66B | $3.37B |